Why Repligen (RGEN) Shares Are Trading Lower Today
Update: 2025-10-29
Description
Repligen's stock dropped around four percent despite beating analysts' expectations, as the company lowered its full-year adjusted earnings forecast. The volatile stock, known for significant moves, saw a less dramatic drop than usual. Broader market forces, including US-China trade tensions, also impacted the biopharma sector. Despite a year-to-date gain of nearly eight percent, Repligen's stock is still down twelve percent from its January peak and underwater for long-term investors.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
